Literature DB >> 33783750

Health-Promoting Functions of the Marine Carotenoid Fucoxanthin.

Masashi Hosokawa1.   

Abstract

Fucoxanthin (Fx) is a marine carotenoid found in brown seaweeds and several marine microalgae. Recent studies have reported that dietary Fx exhibits many health-promoting functions such as anti-obesity and anti-diabetic effects in animal experiments. A human clinical trial of Fx showed high potential on reduction of body weight and fat content. The anti-obesity effect of Fx is due to several mechanisms, which include the suppression of adipocyte differentiation, anti-inflammation, and uncouple protein 1 induction in white adipose tissue. Furthermore, Fx reduced blood glucose level and improved insulin resistance through the regulation of adipokine mRNA expressions. In this chapter, we reviewed health beneficial effects and safety of Fx and discussed their molecular mechanisms.

Entities:  

Keywords:  Amarouciaxanthin A; Anti-diabetic effect; Anti-obesity effect; Brown seaweeds; Fucoxanthin; Fucoxanthinol

Mesh:

Substances:

Year:  2021        PMID: 33783750     DOI: 10.1007/978-981-15-7360-6_25

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  43 in total

1.  Modest PGC-1alpha overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria.

Authors:  Carley R Benton; James G Nickerson; James Lally; Xiao-Xia Han; Graham P Holloway; Jan F C Glatz; Joost J F P Luiken; Terry E Graham; John J Heikkila; Arend Bonen
Journal:  J Biol Chem       Date:  2007-12-12       Impact factor: 5.157

2.  Effect of brown seaweed lipids on fatty acid composition and lipid hydroperoxide levels of mouse liver.

Authors:  M K Widjaja-Adhi Airanthi; Naoya Sasaki; Sayaka Iwasaki; Nobuko Baba; Masayuki Abe; Masashi Hosokawa; Kazuo Miyashita
Journal:  J Agric Food Chem       Date:  2011-03-30       Impact factor: 5.279

Review 3.  Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis.

Authors:  R B Ceddia
Journal:  Int J Obes (Lond)       Date:  2005-10       Impact factor: 5.095

4.  In vitro and in vivo evaluation of mutagenicity of fucoxanthin (FX) and its metabolite fucoxanthinol (FXOH).

Authors:  Fumiaki Beppu; Yoshimi Niwano; Emiko Sato; Masahiro Kohno; Takayuki Tsukui; Masashi Hosokawa; Kazuo Miyashita
Journal:  J Toxicol Sci       Date:  2009-12       Impact factor: 2.196

5.  The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat.

Authors:  M Abidov; Z Ramazanov; R Seifulla; S Grachev
Journal:  Diabetes Obes Metab       Date:  2009-10-13       Impact factor: 6.577

6.  Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss.

Authors:  Paul Cohen; Makoto Miyazaki; Nicholas D Socci; Aaron Hagge-Greenberg; Wolfgang Liedtke; Alexander A Soukas; Ratnendra Sharma; Lisa C Hudgins; James M Ntambi; Jeffrey M Friedman
Journal:  Science       Date:  2002-07-12       Impact factor: 47.728

7.  Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: formation and cytotoxicity of fucoxanthin metabolites.

Authors:  Akira Asai; Tatsuya Sugawara; Hiroshi Ono; Akihiko Nagao
Journal:  Drug Metab Dispos       Date:  2004-02       Impact factor: 3.922

8.  Single and repeated oral dose toxicity study of fucoxanthin (FX), a marine carotenoid, in mice.

Authors:  Fumiaki Beppu; Yoshimi Niwano; Takayuki Tsukui; Masashi Hosokawa; Kazuo Miyashita
Journal:  J Toxicol Sci       Date:  2009-10       Impact factor: 2.196

9.  Low bioavailability of dietary epoxyxanthophylls in humans.

Authors:  Akira Asai; Lina Yonekura; Akihiko Nagao
Journal:  Br J Nutr       Date:  2008-08       Impact factor: 3.718

10.  Effects of dietary fucoxanthin on cholesterol metabolism in diabetic/obese KK-A(y) mice.

Authors:  Fumiaki Beppu; Masashi Hosokawa; Yoshimi Niwano; Kazuo Miyashita
Journal:  Lipids Health Dis       Date:  2012-09-10       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.